Related Experiment Video
Updated: Jul 12, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
A futile metabolic cycle activated in adipocytes by antidiabetic agents
Hong-Ping Guan1, Yong Li, Mette Valentin Jensen
1Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine and The Penn Diabetes Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Abstract:
Thiazolidinediones (TZDs) are effective therapies for type 2 diabetes, which has reached epidemic proportions in industrialized societies. TZD treatment reduces circulating free fatty acids (FFAs), which oppose insulin actions in skeletal muscle and other insulin target tissues. Here we report that TZDs, acting as ligands for the nuclear receptor peroxisome proliferator-activated receptor (PPAR)-gamma, markedly induce adipocyte glycerol kinase (GyK) gene expression. This is surprising, as standard textbooks indicate that adipocytes lack GyK and thereby avoid futile cycles of triglyceride breakdown and resynthesis from glycerol and FFAs. By inducing GyK, TZDs markedly stimulate glycerol incorporation into triglyceride and reduce FFA secretion from adipocytes. The 'futile' fuel cycle resulting from expression of GyK in adipocytes is thus a novel mechanism contributing to reduced FFA levels and perhaps insulin sensitization by antidiabetic therapies.
Insights
Thiazolidinediones (TZDs) reduce free fatty acids in type 2 diabetes by activating PPAR-gamma. This induces glycerol kinase in fat cells, promoting triglyceride synthesis and lowering fatty acids.
Area of Science:
- Metabolic diseases
- Endocrinology
- Molecular biology
Background:
- Type 2 diabetes is a global health issue.
- Thiazolidinediones (TZDs) are key antidiabetic drugs.
- TZDs lower circulating free fatty acids (FFAs), which impair insulin sensitivity.
Purpose of the Study:
- To investigate the mechanism by which TZDs reduce FFAs.
- To explore the role of adipocyte glycerol kinase (GyK) in TZD action.
Main Methods:
- Studied the effect of TZDs on gene expression in adipocytes.
- Analyzed glycerol incorporation into triglycerides.
- Measured FFA secretion from adipocytes.
Main Results:
- TZDs, as PPAR-gamma ligands, strongly induce GyK gene expression in adipocytes.
- Induced GyK stimulates glycerol metabolism, increasing triglyceride synthesis.
- This process reduces FFA secretion from adipocytes.
Conclusions:
- Adipocyte GyK induction by TZDs is a novel mechanism for reducing FFAs.
- This pathway may contribute to the insulin-sensitizing effects of TZD therapies.
- The findings challenge existing textbook knowledge on adipocyte metabolism.
More Related Videos
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Metabolic States of the Body: The Postabsorptive State
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Insulin: The Receptor and Signaling Pathways
Type II Diabetes II: Pathophysiology

